bell
The current prices are delayed by 15 mins, login to check live prices.
Fermenta Biotech Ltd share price logo

Fermenta Biotech Ltd

(506414)

₹326.21.51%

as on 04:01PM, 21 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Fermenta Biotech Ltd Share analysis

Excluding Excise Duty and Other Income, represents Net Revenue

Fermenta Biotech Ltd revenue growth forecast

Expected growth rate , :0

Forecast

Actual

Source: S&P Global Market Intelligence

Fermenta Biotech Ltd Performance

  • Day's Low

    Day's High

    ₹322.05
    ₹335
  • 52 Week's Low

    52 Week's High

    ₹145
    ₹354.6
1 Month Return+ 10.92 %
3 Month Return+ 6.63 %
1 Year Return+ 112.1 %
Previous Close₹331.20
Open₹324.00
Volume16.26K
Upper Circuit-
Lower Circuit-
Market Cap₹974.75Cr

Fermenta Biotech Ltd Key Statistics

P/E Ratio113.04
PEG Ratio4.71
Market Cap₹974.75 Cr
P/B Ratio1.39
EPS-8.31
Dividend Yield0.81
SectorPharmaceuticals
ROE-2.38

Fermenta Biotech Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹974.75 Cr11.27%0.68-₹25 Cr₹335 Cr
NA₹143.16 Cr73.55%0.56NANA
NA₹1,388.42 Cr84.92%0.51₹25 Cr₹212 Cr
NA₹35.53 Cr14.76%0.54NANA
NA₹111.21 Cr51.29%0.55NANA

About Fermenta Biotech Ltd

DupharInterfran (DIL) was established by a technocrat, D V K Raju in 1951 as International Franchises Pvt Ltd. In the early years, the company manufactured and sold toothpaste, antiseptic lotion and pharmaceutical specialities on a loan licence basis, in collaboration with PhilipsDuphar Amsterdam Solvay Duphar and Crookes Laboratories London (participation up to 25% equity). The company changed its name to Crookes Interfran in 1963 and to DupharInterfran in 1971. In 1976, collaborations with Solvay Duphar for manufacturing Vitamin D3 and Isoxypurine hydrochloride, with 38.86% foreign stake, came up. In 1995, DIL launched a rights issue to increase long-term resources and working capital and sold two popular brands - Crocin and LactoCalamine lotion - to Smithkline Beecham Pharmaceuticals and Nicholas Piramal respectively to concentrate on the core business of ethical drugs. As per the Scheme of Arrangement, the pharma business of the company was also transferred to a new entity called Duphar Pharma India and investments in unutilised premises at Thane for a commercial complex with modern facilities were also made. In 2003, the Company expanded manufacturing capacity for Vitamin D and other products like Phenyramidol in Kullu. In 2010, the company signed a contract with Solvay Pharmaceuticals B V in Netherlands and acquired 990000 equity shares of Rs.10 each from Fermenta Biotech Ltd, making it a subsidiary. In 2012, the company launched Penicillin G Acylase catalyst Fermase PA 850 and successful entries of Annual Contract with Solvay Pharmaceuticals B V, a vasodilator. Since then, the company has launched new and improved products - fish oil derived cholesterol for the aquaculture market, Vitamin D 500 feed grade powder in 2020, Vitamin AD2 for oil fortification, and patented technology for enzymatic synthesis of Molnupiravir in 2021. It also established subsidiaries in Mauritius, Germany, and USA. The company changed its name from DIL Limited to Fermenta Biotech Limited (FBL) in 2019.

Share Price: ₹326.20 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹974.75Cr as of today
Revenue: ₹95.03Cr as on September 2024 (Q3 24)
Net Profit: ₹11.12Cr as on September 2024 (Q3 24)
Chairperson Name: Pradeep Manjunath Chandan
OrganisationFermenta Biotech Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Fermenta Biotech Ltd

  • Fermenta Bio Reports Decline in Net Sales and Losses - 22 Aug, 2024

    Fermenta Bio's consolidated net sales for June 2024 fell 5.24% to Rs 78.13 crore, with a quarterly net loss of Rs 5.82 crore. EBITDA also decreased by 72.05%. Despite these declines, the stock has shown significant returns of 60.14% over the last six months and 107.55% over the past year.

Insights on Fermenta Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, Fermenta Biotec. stock has moved up by 105.3%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 36.11% to 36.42% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 80.95 Cr → 97.91 Cr (in ₹), with an average increase of 17.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Fermenta Biotec. has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 0.05% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -6.94 Cr → 11.38 Cr (in ₹), with an average increase of 85.2% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 62.06% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 108.9%

Fermenta Biotech Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹56.91Cr (-)₹98.97Cr (↑73.91%)₹97.34Cr (↓1.65%)₹78.13Cr (↓19.73%)₹95.03Cr (↑21.63%)
Net Income-₹29.07Cr (-)₹9.99Cr (↓134.37%)-₹7.14Cr (↓171.47%)-₹5.93Cr (↓16.95%)₹11.12Cr (↓287.52%)
Net Profit Margin-51.08% (-)10.09% (↓119.75%)-7.34% (↓172.75%)-7.59% (↑3.41%)11.70% (↓254.15%)
Value in ₹ crore
Details2021202220232024
Total Assets₹702.95Cr (-)₹736.89Cr (↑4.83%)₹701.94Cr (↓4.74%)₹608.79Cr (↓13.27%)
Total Liabilities₹332.51Cr (-)₹340.92Cr (↑2.53%)₹365.88Cr (↑7.32%)₹294.56Cr (↓19.49%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹29.83Cr (-)₹62.96Cr (↑111.06%)₹50.41Cr (↓19.93%)₹123.75Cr (↑145.49%)₹105.02Cr (↓15.14%)
0

Fermenta Biotech Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
62.06%
0.00
Foreign Institutions
0.05%
0.00
Mutual Funds
0%
0.00
Retail Investors
36.42%
0.84
Others
1.47%
-19.34

Fermenta Biotech Ltd Key Indicators

Details20202021202220232024
Return On Equity %22.6515.227.890.84-2.38
Details20202021202220232024
Return On Assets %9.536.472.1-7.28-3.79
Details20202021202220232024
Book Value Per Share (₹)107.27125129109.27100.04
Details20202021202220232024
Earning Per Share (₹)20.6314.745.22-18.41-8.31

Fermenta Biotech Ltd Valuation

Fermenta Biotech Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-55.80x)

October 6, 2022

Industry (54.42x)

November 19, 2024

Today (113.04x)

November 19, 2024

Highest (473.02x)

September 6, 2022

LowHigh

Fermenta Biotech Ltd Earnings and Dividends

  • Fermenta Biotech Ltd Earnings Results

    Fermenta Biotech Ltd’s net profit jumped 139.85% since last year same period to ₹11.38Cr in the Q2 2024-2025. On a quarterly growth basis, Fermenta Biotech Ltd has generated 295.53% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Fermenta Biotech Ltd Dividends May,2024

    In the quarter ending March 2024, Fermenta Biotech Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.77%.

    Read More about Dividends

Fermenta Biotech Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Fermenta Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Fermenta Biotech Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Fermenta Biotech Ltd shares.

Fermenta Biotech Ltd (506414) share price today is ₹326.2

Fermenta Biotech Ltd is not listed on NSE

Fermenta Biotech Ltd is listed on BSE

  • Today’s highest price of Fermenta Biotech Ltd is ₹335.
  • Today’s lowest price of Fermenta Biotech Ltd is ₹322.05.

PE Ratio of Fermenta Biotech Ltd is 113.04

PE ratio = Fermenta Biotech Ltd Market price per share / Fermenta Biotech Ltd Earnings per share

Today’s traded volume of Fermenta Biotech Ltd(506414) is 16.26K.

Today’s market capitalisation of Fermenta Biotech Ltd(506414) is ₹974.75Cr.

Fermenta Biotech Ltd(506414Price
52 Week High
₹354.6
52 Week Low
₹145

Fermenta Biotech Ltd(506414) share price is ₹326.2. It is down -8.01% from its 52 Week High price of ₹354.6

Fermenta Biotech Ltd(506414) share price is ₹326.2. It is up 124.97% from its 52 Week Low price of ₹145

Fermenta Biotech Ltd(506414Returns
1 Day Returns
-5%
1 Month Returns
10.92%
3 Month Returns
6.63%
1 Year Returns
112.1%